Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy

Download (PDF)

Sources of advice and support

Crohns and Colitis UK, 01727 8300 385, www.crohnsandcolitis.org.uk
IA (the ileostomy and internal pouch support group), 0800 0184 724, www.iasupport.org

NICE is not responsible for the quality or accuracy of any information or advice provided by these organisations.

ISBN 978-1-4731-1006-9